$30.14 +0.39 (1.31%) Sarepta Therapeutics Inc - NASDAQ

Jul. 2, 2015 | 04:00 PM
Key Statistics
Last Trade: 30.14
Trade Time: Jul 02 04:00 PM Eastern Daylight Time
Change: +0.39 (1.31%)
Prev Close: 29.75
Open: 29.69
Bid: 30.12
Ask: 30.14

Competitors

Ticker Name Volume % Change
PFE Pfizer Inc 22.45M -0.95%
SGYP Synergy Pharmaceuticals Inc 12.15M +1.98%
MRK Merck & Co Inc 8.48M +0.12%
SNSS Sunesis Pharmaceuticals Inc 7.42M -0.62%
MNKD MannKind Corp 7.32M -4.57%

SRPT Stock Analysis

Partner Headlines

  1. 2 DMD drugs make progress

    IBD | Jun. 29, 2015 | 18:45PM EST
  2. BioMarin, Sarepta Muscular Dystrophy Drugs Progress

    IBD | Jun. 29, 2015 | 10:18AM EST
  3. Sarepta Therapeutics Completes NDA Submission to FDA for Eteplirsen for the Treatment ...

    Benzinga | Jun. 29, 2015 | 07:01AM EST
  4. Benzinga's Top Upgrades

    Benzinga | Jun. 22, 2015 | 09:07AM EST
  5. Benzinga's Top Downgrades

    Benzinga | May. 21, 2015 | 08:50AM EST
  6. Sarepta Therapeutics Inc (SRPT) Will File NDA; Analysts Have Mixed Ratings

    GuruFocus | May. 20, 2015 | 19:28PM EST
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!